Paolo Bruzzi Selected Research

Squamous Cell Carcinoma of Head and Neck

1/2020	Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700).
1/2019	Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Bruzzi Research Topics

Disease

46	Breast Neoplasms (Breast Cancer) 09/2022 - 06/2002
37	Neoplasms (Cancer) 01/2022 - 06/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 10/2009
4	COVID-19 10/2022 - 01/2021
4	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 03/2014
4	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2003
4	Fever (Fevers) 01/2021 - 04/2003
4	Infections 01/2018 - 04/2003
3	Disease Progression 12/2021 - 02/2018
3	Neutropenia 01/2018 - 05/2015
3	Cardiotoxicity 10/2017 - 05/2009
3	Multiple Sclerosis 07/2013 - 03/2005
3	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 06/2002
2	Pneumonia (Pneumonitis) 10/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 07/2020 - 01/2015
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 10/2019 - 02/2018
2	Lung Neoplasms (Lung Cancer) 12/2018 - 03/2007
2	Leukemia 01/2018 - 04/2003
2	Hodgkin Disease (Hodgkin's Disease) 10/2017 - 10/2017
2	Thrombocytopenia (Thrombopenia) 01/2017 - 12/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 04/2015
2	Sepsis (Septicemia) 05/2016 - 04/2007
2	Myocardial Infarction 04/2015 - 01/2006
2	Insulin Resistance 10/2013 - 07/2012
2	Chills 05/2010 - 01/2010
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2007 - 01/2002
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2022

Drug/Important Bio-Agent (IBA)

13	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 07/2002
10	AnthracyclinesIBA 01/2020 - 07/2002
9	Biomarkers (Surrogate Marker)IBA 02/2019 - 06/2002
7	Estrogen ReceptorsIBA 05/2016 - 12/2005
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 07/2002
6	Pharmaceutical PreparationsIBA 10/2019 - 01/2010
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 08/2004
6	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 07/2002
5	Docetaxel (Taxotere)FDA Link 01/2020 - 10/2008
4	Hormones (Hormone)IBA 10/2021 - 10/2011
4	NivolumabIBA 01/2020 - 01/2019
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 08/2006
3	Tamoxifen FDA LinkGeneric 10/2021 - 09/2006
3	Insulin (Novolin)FDA Link 06/2021 - 07/2012
3	Metformin (Glucophage)FDA LinkGeneric 05/2020 - 07/2012
3	Ifosfamide FDA LinkGeneric 01/2020 - 03/2014
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 02/2014
3	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 01/2017
3	Gemcitabine FDA Link 01/2020 - 03/2013
2	Monoclonal AntibodiesIBA 12/2021 - 10/2008
2	Letrozole (Femara)FDA LinkGeneric 10/2021 - 08/2006
2	C-Reactive ProteinIBA 01/2021 - 11/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2011
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2017
2	Cetuximab (Erbitux)FDA Link 01/2020 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2019
2	TrabectedinIBA 01/2020 - 01/2017
2	LigandsIBA 10/2019 - 01/2010
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 07/2002
2	SmokeIBA 01/2018 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 07/2012
2	ParaffinIBA 05/2013 - 01/2009
2	Filgrastim (Neupogen)FDA Link 01/2013 - 12/2005
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2013 - 12/2005
2	human CNGRC fusion protein tumor necrosis factor-alphaIBA 05/2010 - 01/2010
2	Peptides (Polypeptides)IBA 05/2010 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 10/2003
2	CD13 Antigens (Alanine Aminopeptidase)IBA 05/2010 - 01/2010
2	Protein Isoforms (Isoforms)IBA 05/2010 - 01/2010
2	Trastuzumab (Herceptin)FDA Link 05/2009 - 10/2008
2	Cisplatin (Platino)FDA LinkGeneric 03/2007 - 10/2002
1	GlucocorticoidsIBA 10/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	Methylprednisolone FDA LinkGeneric 10/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	AnticoagulantsIBA 12/2021
1	Insulin-Like PeptidesIBA 06/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	ChromatinIBA 01/2021

Therapy/Procedure

28	Drug Therapy (Chemotherapy) 01/2022 - 06/2002
26	Therapeutics 10/2022 - 04/2003
10	Adjuvant Chemotherapy 01/2017 - 07/2002
9	Neoadjuvant Therapy 02/2022 - 01/2013
4	Radiotherapy 02/2022 - 02/2003
3	Lymph Node Excision (Lymph Node Dissection) 09/2022 - 01/2016
3	Induction Chemotherapy 01/2020 - 07/2004
2	Immunotherapy 01/2021 - 11/2005
2	Chemoradiotherapy 01/2020 - 07/2004
2	Catheters 05/2016 - 07/2012
2	Aftercare (After-Treatment) 01/2011 - 08/2006
2	Transplantation 05/2009 - 05/2006
2	Stem Cell Transplantation 05/2009 - 11/2005
2	Hematopoietic Stem Cell Transplantation 04/2007 - 03/2005
2	Combination Drug Therapy (Combination Chemotherapy) 03/2007 - 08/2006
1	Segmental Mastectomy (Lumpectomy) 09/2022
1	Mastectomy (Mammectomy) 09/2022
1	Noninvasive Ventilation 12/2021
1	Continuous Positive Airway Pressure 12/2021
1	Investigational Therapies (Experimental Therapy) 01/2021